Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	116.59	139.04	143.94	87.88	149.1	251.25
Cash & Short-Term Investments	116.59	139.04	143.94	87.88	149.1	251.25
Cash Growth	-5.96%	-3.41%	63.79%	-41.06%	-40.66%	-
Prepaid Expenses	2.06	1.36	1.09	2.51	3.87	3.83
Restricted Cash	0.45	0.45	0.45	-	-	-
Other Current Assets	1.6	1.28	4.39	6.03	6.63	2.79
Total Current Assets	120.71	142.13	149.87	96.42	159.6	257.88
Property, Plant & Equipment	15.32	15.87	20.41	25.91	50.61	0.29
Other Long-Term Assets	2.34	2.37	2.46	3.95	3.74	0.72
Total Assets	138.36	160.36	172.73	126.28	213.96	258.88
Accounts Payable	4.33	3.59	6.37	10.95	21.76	1.99
Accrued Expenses	7.81	9.59	9.46	14.04	25.85	4.87
Current Portion of Leases	1.81	1.88	1.65	1.52	-	-
Current Unearned Revenue	7.47	9.77	18.11	33.56	-	-
Other Current Liabilities	1.14	1.4	1.18	2.73	4.14	0.26
Total Current Liabilities	22.56	26.23	36.76	62.79	51.75	7.13
Long-Term Debt	42.45	43.94	40.51	37.97	37.19	-
Long-Term Leases	17.37	17.74	18.95	20.44	25.9	-
Other Long-Term Liabilities	0.93	0.93	1.58	4.13	3.74	0.45
Total Liabilities	83.3	88.84	97.79	125.33	118.57	7.58
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	681.18	677.86	587.94	402.39	331.03	312.43
Retained Earnings	-623.83	-602.31	-513.01	-401.44	-235.65	-61.13
Comprehensive Income & Other	-2.29	-4.03	-	-	-	-
Shareholders' Equity	55.06	71.53	74.94	0.95	95.38	251.3
Total Liabilities & Equity	138.36	160.36	172.73	126.28	213.96	258.88
Total Debt	61.63	63.56	61.11	59.93	63.09	-
Net Cash (Debt)	54.96	75.48	82.83	27.95	86.01	251.25
Net Cash Growth	-12.19%	-8.88%	196.34%	-67.50%	-65.77%	-
Net Cash Per Share	0.21	0.30	0.71	0.64	2.28	14.22
Filing Date Shares Outstanding	214.66	205	187.02	63.47	38.47	37.76
Total Common Shares Outstanding	205.05	204.94	186.96	63.21	38.47	37.76
Working Capital	98.15	115.9	113.11	33.63	107.86	250.75
Book Value Per Share	0.27	0.35	0.40	0.02	2.48	6.65
Tangible Book Value	55.06	71.53	74.94	0.95	95.38	251.3
Tangible Book Value Per Share	0.27	0.35	0.40	0.02	2.48	6.65
Machinery	4.69	4.7	4.87	4.88	3.04	0.1
Construction In Progress	4.25	4.25	6.82	9.63	46	0.2
Leasehold Improvements	2.12	2.12	2.12	2.09	2.07	-

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q